Skip to search formSkip to main contentSkip to account menu

peldesine

Known as: Peldesina, 9-(3-Pyridinylmethyl)-7H-9-deazaguanine, 9-(3-pyridylmethyl)-7H-9-deazaguanine 
A pyrimidine analogue and purine nucleoside phosphorylase inhibitor with immunosuppressive and antineoplastic properties. Peldesine inhibits purine… 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

BCX 34

Broader (1)

Guanine
NCIt Antineoplastic Agent Terminologyanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review
The authors performed a systematic review of randomized controlled trials (RCTs) on interventions for any stage of typical… 
Review
2000
Review
2000
An oncologist's approach to therapy for cutaneous T-cell lymphoma.
Cutaneous T-cell lymphoma (CTCL) includes a heterogeneous group of diseases manifested in many cases by a prolonged clinical… 
1999
1999
Preformulation studies for the development of a parenteral liquid formulation of the immunomodulator, peldesine.
Peldesine (BCX-34) is a potent inhibitor of the enzyme purine nucleoside phosphorylase (PNP). The object of this study was to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)